,
Jiang, Wei
Yu, Xiangyou
Sun, Tongwen
Chai, Yanfen
Chang, Ping
Chen, Zhongqing
Pan, Jingye
Peng, Zhiyong
Wang, Ruilan
Wang, Xiaozhi
Xu, Yuan
Yu, Li
Zheng, Qingshan
Du, Bin
Funding for this research was provided by:
Guangdong Techpool Biopharmaceutical Co, Ltd (N/A)
Article History
Received: 4 June 2017
Accepted: 30 January 2018
First Online: 21 February 2018
Ethics approval and consent to participate
: The protocol and the informed consent document have been reviewed and approved by the Institutional Ethics Committee of all participating centers (TableĀ ). Study investigators will provide potential participants with verbal and written information prior to inclusion in the study. Informed consent will be provided from participants or their authorized representatives.
: Not applicable. Results will be presented at relevant national and international conferences as well as being published in peer-reviewed journals.
: The principle investigator, Professor Bin Du, will be paid a management fee for this trial according to the contract. All the other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.